Phoenix, Arizona–(Newsfile Corp. – April 22, 2024) – SinglePoint Inc. (Cboe BZX: SING), a leading firm in renewable energy in the residential and small commercial solar sector, provides an update regarding the delay in filing its annual report on Form 10-K for the fiscal year ended December 31, 2023 (the “2023 Annual Financial Statements”). The […]

NEW YORK, NY / ACCESSWIRE / April 23, 2024 / 1847 Holdings LLC (“1847” or the “Company”) (NYSE American:EFSH), a holding company specializing in identifying over-looked, deep value investment opportunities in middle market businesses, today announced the execution of a non-binding Letter of Intent (“LOI”) with a prospective strategic buyer to sell all assets of 1847 Cabinets […]

SAN DIEGO, April 23, 2024 (GLOBE NEWSWIRE) — Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel classes of therapeutic drugs that modulate the endocannabinoid system, today announced that Chief Executive Officer & Chair Punit Dhillon and other members of Skye’s executive team will present […]

PowerPort Neo is Available for Immediate Orders from Nuvve  SAN DIEGO, April 22, 2024 /PRNewswire/ — Nuvve Holding Corp. (the “Company”) (Nasdaq: NVVE), a global technology leader accelerating the electrification of transportation through its proprietary vehicle-to-grid (V2G) platform, is pleased to announce the release of upgraded PowerPort Electric Vehicle Supply Equipment (EVSE) models, boasting hardware enhancements and […]

Nashville, TN, April 22, 2024 (GLOBE NEWSWIRE) — American Rebel Holdings, Inc. (NASDAQ: AREB) (“American Rebel” or the “Company”), a designer, manufacturer, and marketer of branded safes, personal security and self-defense products and apparel, and American Rebel Beer (www.americanrebelbeer.com), is proud to announce a distribution agreement with Best Brands Inc (www.bestbrandsinc.com) for the state of […]

70% of Patients in the Expanded Access Program (EAP) Have Seen Measurable Clinical Improvement in Their Fatigue After Six Months of Follow-up All Patients Have Either Stabilized or Improved on Nasal Foralumab Treatment and No Patients Declined in Key Clinical Measures NEW YORK, April 22, 2024 (GLOBE NEWSWIRE) — Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) […]

– Intranasal foralumab attenuated microglial activation in patients with non-active secondary progressive multiple sclerosis and progression independent of relapse (PIRA) – – Data presented in a platform session at the Annual Meeting of the American Academy of Neurology in Denver, Colorado – NEW YORK, April 19, 2024 (GLOBE NEWSWIRE) — Tiziana Life Sciences, Ltd. (Nasdaq: […]

SANTA ANA, Calif., April 18, 2024 (GLOBE NEWSWIRE) — NKGen Biotech, Inc. (Nasdaq: NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous, allogeneic and CAR-NK natural killer (“NK”) cell therapeutics, today announced that Paul Y. Song, MD, Chairman and Chief Executive Officer of NKGen Biotech, will […]